Related Experiment Video
Updated: Dec 18, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive
Hirayuki Enomoto1, Hideji Nakamura2, Hiroki Nishikawa1
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine Nishinomiya, Hyogo 663-8501, Japan.
Abstract:
Hepatoma-derived growth factor (HDGF) was identified in research seeking to find a novel growth factor for hepatoma cells. Subsequently, four HDGF-related proteins were identified, and these proteins are considered to be members of a new gene family. HDGF has a growth-stimulating role, an angiogenesis-inducing role, and a probable anti-apoptotic role. HDGF is ubiquitously expressed in non-cancerous tissues, and participates in organ development and in the healing of damaged tissues. In addition, the high expression of HDGF was reported to be closely associated with unfavorable clinical outcomes in several malignant diseases. Thus, HDGF is considered to contribute to the development and progression of malignant disease. We herein provide a brief overview of the factor and its functions in relation to benign and malignant cells. We also describe its possible role as a target molecule for digestive malignancies.
Insights
Hepatoma-derived growth factor (HDGF) promotes cell growth and survival. Its dysregulation is linked to cancer progression, suggesting HDGF as a potential therapeutic target for digestive malignancies.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Hepatoma-derived growth factor (HDGF) was initially identified as a novel growth factor for hepatoma cells.
- HDGF and four related proteins form a new gene family, implicated in cell growth, angiogenesis, and apoptosis.
- While HDGF is vital for normal tissue development and repair, its overexpression correlates with poor prognosis in various cancers.
Purpose of the Study:
- To provide an overview of HDGF's functions in both benign and malignant cells.
- To explore the potential of HDGF as a therapeutic target for digestive malignancies.
Main Methods:
- Literature review and synthesis of existing research on HDGF.
- Analysis of HDGF's roles in cellular processes and disease states.
Main Results:
- HDGF exhibits growth-stimulating, angiogenesis-inducing, and anti-apoptotic properties.
- HDGF is widely expressed in normal tissues, aiding organ development and tissue repair.
- Elevated HDGF expression is associated with aggressive clinical outcomes in several cancers.
Conclusions:
- HDGF plays a dual role in normal tissue homeostasis and malignant progression.
- HDGF represents a promising molecular target for the treatment of digestive malignancies.
More Related Videos
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...